Talker on MSN

New state-of-the-art test identifies aggressive prostate cancer

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...
MedPage Today

Evolving Role of PSMA-PET in Metastatic Hormone-Sensitive Prostate Cancer: More Questions Than Answers?

Although most men with metastatic hormone-sensitive prostate cancer (mHSPC) die of prostate cancer (PCa), there remains significant outcome variability, with approximately 18.5% living 10 years or ...
ascopubs.org

Phase IB trial redesign to test role of IL2 with anti-PSMA designer T cells to yield responses in advanced prostate cancer.

Comparison of acute toxicity in patients treated with a 4-field box or IMRT to deliver elective pelvic nodal irradiation for localized high-risk prostate cancer. Background: We created a chimeric ...
ascopubs.org

Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?

Leveraging Circulating Tumor DNA to Optimize the Initial Management of Childhood Renal Tumors Although most men with metastatic hormone-sensitive prostate cancer (mHSPC) die of prostate cancer (PCa), ...
Targeted Oncology

PSMA Discrepancies in Short-Course Enzalutamide for Prostate Cancer

At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...
Business Insider

Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging

Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 medicines in development Quantitative PSMA-PET ...